Education
About Us
Working with TipRanks
Follow Us
INTF - ETF AI Analysis
Top Page
iShares MSCI Intl Multifactor ETF (INTF)
Rating:65Neutral
Price Target:―
Positive Factors
Strong Top Holdings
Several key positions, such as ASML Holding NV and Nestlé SA, have delivered strong year-to-date performance, supporting the ETF's overall returns.
Global Diversification
The ETF has exposure to multiple countries, including Japan, the UK, and France, reducing reliance on any single geographic market.
Low Expense Ratio
With a low expense ratio of 0.16%, this ETF is cost-efficient compared to many other international funds.
Negative Factors
Underperforming Holding
SAP SE, one of the top holdings, has shown weak year-to-date performance, which could drag on the fund's overall returns.
Sector Concentration in Financials
The ETF has a high allocation to the financial sector, which may increase vulnerability to sector-specific risks.
Limited U.S. Exposure
The ETF has minimal exposure to U.S. companies, which could limit participation in the growth of the world's largest economy.
INTF vs. SPDR S&P 500 ETF (SPY)
AUM2.87B
RegionDeveloped Markets
Expense Ratio0.16%
Beta0.71
IssueriShares
Inception DateApr 28, 2015
Dividend Yield2.87%
Asset ClassEquity
Index TrackedSTOXX International Equity Factor
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume230,042
30 Day Avg. Volume201,061
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
40.72Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering458
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
INTF Summary
The iShares MSCI Intl Multifactor ETF (INTF) is an investment fund that focuses on international stocks, using a strategy that combines factors like value, quality, momentum, and size to aim for better returns and lower risk. It tracks the STOXX International Equity Factor index and includes companies from countries like Japan, the UK, and Germany. Some well-known holdings are Novartis AG and ASML Holding NV. This ETF is a good option for investors looking to diversify their portfolio with global exposure. However, since it invests in international markets, its performance can be affected by currency fluctuations and global economic conditions.
How much will it cost me?The iShares MSCI Intl Multifactor ETF (INTF) has an expense ratio of 0.16%, which means you’ll pay $1.60 per year for every $1,000 invested. This is lower than average because it’s passively managed, focusing on tracking a multifactor index rather than active stock selection.
What would affect this ETF?The iShares MSCI Intl Multifactor ETF (INTF) could benefit from growth in developed markets outside the U.S., especially if sectors like financials and technology perform well, as they make up a significant portion of the fund. However, challenges such as rising interest rates or economic slowdowns in these regions could negatively impact key holdings like Novartis and ASML, as well as broader sector performance. Regulatory changes or geopolitical tensions in developed markets may also influence the ETF's future returns.
INTF Top 10 Holdings
The iShares MSCI Intl Multifactor ETF (INTF) leans heavily on developed markets outside the U.S., with a notable tilt toward financials and industrials. Roche Holding AG and UniCredit SpA are rising stars, with Roche benefiting from a strong pharmaceutical pipeline and UniCredit showing impressive profitability and undervaluation. ASML Holding NV also adds momentum with robust revenue growth, though its high valuation tempers enthusiasm. On the flip side, SAP SE is lagging, weighed down by bearish momentum and valuation concerns. Overall, the fund’s sector and geographic diversity provide a balanced yet dynamic international exposure.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Novartis AG | 2.07% | $59.36M | CHF206.54B | 24.00% | 80 Outperform | |
| ASML Holding NV | 1.73% | $49.67M | €344.40B | 31.20% | 76 Outperform | |
| Roche Holding AG | 1.09% | $31.33M | CHF260.13B | 48.38% | 73 Outperform | |
| Royal Bank Of Canada | 1.09% | $31.29M | $237.14B | 40.68% | 75 Outperform | |
| Nestlé SA | 1.05% | $30.06M | CHF199.13B | 19.76% | 71 Outperform | |
| Loblaw Companies | 0.96% | $27.64M | $53.18B | 34.76% | 76 Outperform | |
| AstraZeneca | 0.95% | $27.37M | £211.95B | 30.80% | 80 Outperform | |
| ABB Ltd | 0.87% | $24.98M | kr1.25T | 19.10% | 78 Outperform | |
| SAP SE | 0.87% | $24.97M | €243.69B | -11.67% | 66 Neutral | |
| UniCredit SpA | 0.85% | $24.43M | €109.75B | 107.79% | 75 Outperform |
INTF Technical Analysis
Positive
―
Price Trends
36.23
Positive
35.65
Positive
33.77
Positive
Market Momentum
0.38
Negative
65.80
Neutral
41.90
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For INTF, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 36.85, equal to the 50-day MA of 36.23, and equal to the 200-day MA of 33.77, indicating a bullish trend. The MACD of 0.38 indicates Negative momentum. The RSI at 65.80 is Neutral, neither overbought nor oversold. The STOCH value of 41.90 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for INTF.
INTF Peer Comparison
Comparison Results
Performance Comparison
INTF
iShares MSCI Intl Multifactor ETF
37.64
9.73
34.86%
GSIE
Goldman Sachs ActiveBeta International Equity ETF
―
―
―
LVHI
Legg Mason International Low Volatility High Dividend ETF
―
―
―
IMTM
iShares MSCI Intl Momentum Factor ETF
―
―
―
IDMO
Invesco S&P International Developed Momentum ETF
―
―
―
PXF
Invesco FTSE RAFI Developed Markets ex-U.S. ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents